Syngene International Ltd has provided an update on its acquisition of a biologics manufacturing facility from Stelis Biopharma Ltd, stating that a payment of Rs. 158.2 Crores was made on December 22, 2023, in addition to the initial payment of Rs. 395 Crores made on December 1, 2023.